“…Here, we hypothesized that [Ca 2+ ] i oscillation frequency regulates transcription through a mechanism associated with the cumulated time duration of [Ca 2+ ] i elevations. The cumulated time duration of [Ca 2+ ] i elevations is controlled by frequency, but another determinant is [Ca 2+ ] i spike duration (SD) or [Ca 2+ ] i spike width, which is profoundly modulated by a variety of extracellular and intracellular conditions or physiological and pathophysiological circumstances, such as agonist species and their concentration (Cobbold et al, 1991;Moccia et al, 2003;Morgan and Jacob, 1998;Shuttleworth and Thompson, 1996), extracellular Ca 2+ concentration (Igarashi et al, 1997;Zhao et al, 1990), extracellular pH (Jackson and Thayer, 2006;Zhao et al, 1990), the endoplasmic reticulum Ca 2+ -ATPase (Morgan and Jacob, 1998;Petersen et al, 1993), protein kinase C (PKC) (Young et al, 2002), mitochondria (Jackson and Thayer, 2006) and even temperature (Lee et al, 2005;Schipke et al, 2008;Szekely et al, 2009 ] i oscillation models alone, with a 'Ca 2+ clamp' method (Dolmetsch et al, 1998;Tomida et al, 2003;Zhu et al, 2008), and using [Ca 2+ ] i oscillation models in the concomitant presence of agonist stimulation (Zhu et al, 2008) or repetitive pulses of agonist exposure (Bootman et al, 1994;Morgan and Jacob, 1998), are employed. A human bronchial epithelial cell line, 16HBE, is adapted in these experiments so that it stably expresses histamine receptor, and the responsiveness to the Ca 2+ -dependent pathways of NFkB, Oct and NFAT activity to agonists (Profita et al, 2008;Sidhaye et al, 2008;Weber et al, 2001), including his...…”